Utilization of Direct Acting Oral Anticoagulants in Patients with Liver Cirrhosis: Is It Safe?

Journal Title: Current Trends in Gastroenterology and Hepatology - Year 2018, Vol 1, Issue 2

Abstract

Patients with liver cirrhosis are known to have increased risk of bleeding particularly from gastrointestinal tract. However, recent literature has shown that patients with liver cirrhosis are also at increased risk of thrombotic complications. Therefore, it is important to consider anticoagulation in cirrhotic patients. The purpose of this article is to review the epidemiological studies available in scientific literature comparing the risk of bleeding in cirrhotic patients utilizing DOACs vs traditional anticoagulation

Authors and Affiliations

Saad Qadwai, Tayyaba Rehman, Zeeshan Solangi

Keywords

Related Articles

Pregnancy after Liver Transplantation

In 1978, Walcott and coworkers documented the first pregnancy in a liver transplant recipient [1]. The recipient’s immunosuppressive regimen included prednisone and azathioprine. Her pregnancy was uncomplicated, and she...

Doggy Style Sex Distorts the Appearance of Face

We report many people using doggy style sex invisible lightening of dark under-eye areas, a tightening and lifting effect, harder more brighter-looking skin around their eyes, and older, weaker, penile fracture first tim...

Advanced Hepatocellular Carcinoma in A Scottish Population – Current Experience and the Future

Sorafenib is the current first line standard of care in patients with advanced hepatocellular carcinoma (HCC). Several other drugs are emerging as efficacious agents in this setting. This article will outline our current...

Successful Endoscopic Treatment of Refractory Postoperative Duodenocutaneous Fistula using Fibrin Sealant

Iatrogenic, postoperative enteroatmospheric fistulas remain difficult to manage but common problem after gastrointestinal surgery. Surgical revision, after failure of conservative treatment is not only partially efficien...

Potassium-Competitive Acid Blocker: Novel Class of Anti- Acid Drug

Over the past several decades, great progress has been made on understanding mechanisms of gastric acid secretion for developing new anti-acid drugs. Until now most commonly used anti-acid drugs are histamine-2 receptor...

Download PDF file
  • EP ID EP567577
  • DOI 10.32474/CTGH.2018.01.000106
  • Views 66
  • Downloads 0

How To Cite

Saad Qadwai, Tayyaba Rehman, Zeeshan Solangi (2018). Utilization of Direct Acting Oral Anticoagulants in Patients with Liver Cirrhosis: Is It Safe?. Current Trends in Gastroenterology and Hepatology, 1(2), 18-21. https://europub.co.uk/articles/-A-567577